ArticleOncotarget2016

Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.

Eliza Starczewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.